Skip to content
Search

Latest Stories

GPhC announces 82 per cent pass rate for July registration assessment

The General Pharmaceutical Council (GPhC) this morning (September 9) announced a pass rate of 82 per cent for those who took the July 2021 registration assessment.

A total of 2,907 candidates sat the registration exam across three sittings on July 27, 28 and 29, 2021, with 2,371 of them passing the exam and 536 not succeeding.


Of the total candidates, 2,625 were first-time sitters, 224 were second-time sitters, and 58 attempted for the third time.

In March 2021, 2,666 candidates took the assessment with a passing rate of 88 per cent.

Since 2011, pass rates for the registration assessment have ranged from 72 per cent to 95 per cent, GPhC said.

Congratulating the successful candidates along with the tutors and employers who supported them throughout their training, GPhC chief executive Duncan Rudkin said: “This is a significant achievement, particularly given the challenges with completing their training during the pandemic. We look forward to these candidates joining the register at the earliest possible opportunity.

“We know that candidates who haven’t passed this sitting will be very disappointed. We hope the guidance we have developed will help them understand their options for next steps and are grateful to all of the organisations and individuals across pharmacy who will also provide them with support and advice.”

The GPhC council will discuss the full analysis of the July 2021 registration assessment in October.

Claire Anderson, Royal Pharmaceutical Society president also congratulated candidates passing the registration assessment and achieving the pass rate of 82% -  the second highest since 2016

She added: “We understand that failing an assessment can be disheartening and so we are also able to support those who may have not passed on this occasion. RPS can help them think through their next steps and prepare for a future assessment, or other career options.”

Meanwhile, Thorrun Govind, chair of the RPS in England, once again raised concerns about the "technical glitches" that didn't allow some candidates from completing the assessment in July. She tweeted:

Earlier in August, the RPS had written to GPhC raising concern about this issue.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less